Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

608 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV-UEMS and EORTC Cutaneous Lymphoma Task Force.
Garbe C, Peris K, Soura E, Forsea AM, Hauschild A, Arenbergerova M, Bylaite M, Del Marmol V, Bataille V, Samimi M, Gandini S, Saiag P, Eigentler TK, Lallas A, Zalaudek I, Lebbe C, Grob JJ, Hoeller C, Robert C, Dréno B, Arenberger P, Kandolf-Sekulovic L, Kaufmann R, Malvehy J, Puig S, Leiter U, Ribero S, Papadavid E, Quaglino P, Bagot M, John SM, Richard MA, Trakatelli M, Salavastru C, Borradori L, Marinovic B, Enk A, Pincelli C, Ioannides D, Paul C, Stratigos AJ. Garbe C, et al. Among authors: lebbe c. J Eur Acad Dermatol Venereol. 2020 Oct;34(10):2183-2197. doi: 10.1111/jdv.16849. Epub 2020 Aug 24. J Eur Acad Dermatol Venereol. 2020. PMID: 32840022 Free article. Review.
EDNRB gene variants and melanoma risk in two southern European populations.
Spica T, Fargnoli MC, Hetet G, Bertrand G, Formicone F, Descamps V, Wolkenstein P, Dupin N, Lebbe C, Basset-Seguin N, Saiag P, Cambien F, Grandchamp B, Peris K, Soufir N. Spica T, et al. Among authors: lebbe c. Clin Exp Dermatol. 2011 Oct;36(7):782-7. doi: 10.1111/j.1365-2230.2011.04062.x. Epub 2011 Apr 20. Clin Exp Dermatol. 2011. PMID: 21507037
Visceral lesions occurring during follow-up of melanoma patients: a true place for other diagnosis than melanoma metastasis.
Battistella M, Robert C, Gossot D, Dupuy A, Mateus C, Kérob D, Avril MF, Basset-Seguin N, Lebbé C, de Kerviler E, Viguier M. Battistella M, et al. Among authors: lebbe c. J Eur Acad Dermatol Venereol. 2012 May;26(5):602-10. doi: 10.1111/j.1468-3083.2011.04129.x. Epub 2011 May 25. J Eur Acad Dermatol Venereol. 2012. PMID: 21615526
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.
Robert C, Thomas L, Bondarenko I, O'Day S, Weber J, Garbe C, Lebbe C, Baurain JF, Testori A, Grob JJ, Davidson N, Richards J, Maio M, Hauschild A, Miller WH Jr, Gascon P, Lotem M, Harmankaya K, Ibrahim R, Francis S, Chen TT, Humphrey R, Hoos A, Wolchok JD. Robert C, et al. Among authors: lebbe c. N Engl J Med. 2011 Jun 30;364(26):2517-26. doi: 10.1056/NEJMoa1104621. Epub 2011 Jun 5. N Engl J Med. 2011. PMID: 21639810 Free article. Clinical Trial.
Sentinel lymph node biopsy for melanoma is becoming a consensus: a national survey of French centres involved in melanoma care in 2008.
Lourari S, Paul C, Gouraud PA, Tavitian S, Viraben R, Leccia MT, Saiag P, Lebbe C, Meyer N; Skin Oncology Working Group of the Société Française de Dermatologie (French Society of Dermatology). Lourari S, et al. Among authors: lebbe c. J Eur Acad Dermatol Venereol. 2012 Oct;26(10):1230-5. doi: 10.1111/j.1468-3083.2011.04267.x. Epub 2011 Sep 20. J Eur Acad Dermatol Venereol. 2012. PMID: 21929549
Ipilimumab-induced acute severe colitis treated by infliximab.
Pagès C, Gornet JM, Monsel G, Allez M, Bertheau P, Bagot M, Lebbé C, Viguier M. Pagès C, et al. Among authors: lebbe c. Melanoma Res. 2013 Jun;23(3):227-30. doi: 10.1097/CMR.0b013e32835fb524. Melanoma Res. 2013. PMID: 23458760
Kaposi's sarcoma and pregnancy: case report and literature review.
Brunet-Possenti F, Pages C, Rouzier R, Dupin N, Bagot M, Lebbé C. Brunet-Possenti F, et al. Among authors: lebbe c. Dermatology. 2013;226(4):311-4. doi: 10.1159/000349987. Epub 2013 Jul 2. Dermatology. 2013. PMID: 23838298 Review.
Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study.
McArthur GA, Chapman PB, Robert C, Larkin J, Haanen JB, Dummer R, Ribas A, Hogg D, Hamid O, Ascierto PA, Garbe C, Testori A, Maio M, Lorigan P, Lebbé C, Jouary T, Schadendorf D, O'Day SJ, Kirkwood JM, Eggermont AM, Dréno B, Sosman JA, Flaherty KT, Yin M, Caro I, Cheng S, Trunzer K, Hauschild A. McArthur GA, et al. Among authors: lebbe c. Lancet Oncol. 2014 Mar;15(3):323-32. doi: 10.1016/S1470-2045(14)70012-9. Epub 2014 Feb 7. Lancet Oncol. 2014. PMID: 24508103 Free PMC article. Clinical Trial.
608 results